Inhaled nitric oxide therapy in children.
Inhaled nitric oxide therapy improves oxygenation and reduces the need for treatment with extracorporeal membrane oxygenation in term newborns with hypoxaemic respiratory failure and persistent pulmonary hypertension. In this review, we summarise the current status of iNO therapy in the newborn and the potential role of iNO in other paediatric populations.
Kinsella
John P
JP
Department of Pediatrics, The Children's Hospital and the University of Colorado School of Medicine, Pediatric Heart-Lung Center, Section of Neonatology, Box B-070, 1056 E. 19th Ave., Denver, CO 80218-1088, USA. john.kinmsella@uchsc.edu
Abman
Steven H
SH
D002648:Child; D005865:Gestational Age; D006548:Hernia, Diaphragmatic / Q000628:therapy; D065630:Hernias, Diaphragmatic, Congenital; D006801:Humans; D000860:Hypoxia / Q000628:therapy; D007231:Infant, Newborn; D007234:Infant, Premature; D008991:Monitoring, Physiologic; D009569:Nitric Oxide / Q000008:administration & dosage*; D010102:Oxygen Inhalation Therapy; D015300:Ventilator Weaning; D012122:Ventilators, Mechanical
D009569:Nitric Oxide